TQ also inhibits JAK/STAT and PI3K/Akt/mTOR pathways, and consequently inhibits proliferation of myeloid leukemia cells, suggesting that TQ has potential anti-leukemic effects on both AML and CML cells. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.